Cue Biopharma (CUE) Short-term Investments (2017 - 2025)

Cue Biopharma has disclosed Short-term Investments across 8 years of filings, most recently posting $1.1 million for Q4 2025.

• Short-term Investments for Q4 2025 came in at $1.1 million, up 17.65% year-over-year; the trailing twelve-month figure through Dec 2025 was $1.1 million (up 17.65% YoY), and the FY2025 annual result was $1.1 million, up 17.65% from the prior year.
• Short-term Investments came in at $1.1 million for Q4 2025 at Cue Biopharma, down from $7.0 million in the prior quarter.
• In the past five years, Short-term Investments ranged from a high of $29.5 million in Q3 2022 to a low of $287000.0 in Q4 2023.
• The 4-year median for Short-term Investments is $3.0 million (2023), against an average of $8.0 million.
• Across the five-year window, Short-term Investments tumbled 98.84% in 2023 and surged 223.69% in 2024, its largest moves.
• Cue Biopharma's Short-term Investments stood at $24.7 million in 2022, then sank by 98.84% to $287000.0 in 2023, then soared by 223.69% to $929000.0 in 2024, then rose by 17.65% to $1.1 million in 2025.
• The last three Short-term Investments figures came in at $1.1 million (Q4 2025), $7.0 million (Q3 2025), and $470000.0 (Q2 2025), per Business Quant data.